Keyphrases
Healthy Controls
100%
Gene Expression
100%
Healthy Individuals
100%
Multiple Sclerosis
100%
CD25 Expression
100%
Rs2104286
100%
Soluble CD25
100%
False Discovery Rate
50%
Peripheral Blood Mononuclear Cells
50%
IL2RA
50%
Multiple Sclerosis Treatment
33%
SNP
33%
Gene Expression Level
33%
Microarray
16%
Plasma Concentration
16%
Genome-wide Association Study
16%
Heart Rate Correction
16%
Patient-controlled
16%
Genotype Groups
16%
Differentially Expressed
16%
Relapsing-remitting multiple Sclerosis
16%
Progressive multiple Sclerosis
16%
Immunological Changes
16%
Innate Immune Response
16%
Spearman
16%
Affymetrix
16%
Secondary Progressive
16%
CD25
16%
NFKB1
16%
High Correlation
16%
Human Genes
16%
Fine Mapping
16%
Soluble interleukin-2 Receptor (sIL-2R)
16%
BCL6
16%
Gene Network
16%
Immunology and Microbiology
Gene Expression
100%
Multiple Sclerosis
100%
CD25
100%
Peripheral Blood Mononuclear Cell
42%
Single Nucleotide Polymorphism
28%
Gene Expression Level
28%
Blood Level
14%
Primary Progressive Multiple Sclerosis
14%
Relapsing Remitting Multiple Sclerosis
14%
ELISA
14%
Innate Immune System
14%
Tumor Necrosis Factor
14%
Genome-Wide Association Study
14%
Interleukin 2 Receptor
14%
BCL6
14%
STAT1
14%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
CD25
100%
Peripheral Blood Mononuclear Cell
42%
IL2RA
42%
Single Nucleotide Polymorphism
28%
Gene Expression Level
28%
Genotyping
14%
Blood Level
14%
Eicosanoid Receptor
14%
Microarrays
14%
Genome-Wide Association Study
14%
Tumor Necrosis Factor
14%
Interleukin 2
14%
Innate Immunity
14%
STAT1
14%
NFKB1
14%
Gene Network
14%
BCL6
14%
Neuroscience
Gene Expression
100%
Multiple Sclerosis
100%
False Discovery Rate
60%
Peripheral Blood Mononuclear Cell
60%
Genome-Wide Association Study
20%
Microarrays
20%
Primary Progressive Multiple Sclerosis
20%
Relapsing Remitting Multiple Sclerosis
20%
ELISA
20%
NFKB1
20%
Interleukin 2 Receptor
20%
BCL6
20%
STAT1
20%